Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma.

Curr Oncol · 2025 · PMC11941608 · PMID 40136328

Europe PMC DOI

hedged sentence

0.4800

closest p · 9.6× alpha

0.4800

boldest claim

The sentences

did not reach statistical significancep = 0.48not close (p > 0.1)

Median overall survival was 7.4 and 16.1 months for the hypo-RT and conv-RT groups, respectively, but this difference did not reach statistical significance ( p = 0.48).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.